Stock HUN HUNTSMAN CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Huntsman Corporation

Equities

HUN

US4470111075

Diversified Chemicals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
23.99 USD +1.35% Intraday chart for Huntsman Corporation +1.14% -4.54%
Apr. 08 UBS Raises Huntsman's Price Target to $27 From $26, Maintains Neutral Rating MT
Mar. 22 John Chevedden Submits a Shareholder Proposal to Huntsman Corporation CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,447 5,551 7,605 5,279 4,380 4,150 - -
Enterprise Value (EV) 1 7,311 6,079 8,114 6,362 5,528 5,456 5,503 5,502
P/E ratio 9.9 x 5.39 x 7.39 x 12.1 x 44.1 x 42.9 x 13.9 x -8.95 x
Yield 2.69% 2.59% 2.15% 3.09% 3.78% 4.11% 4.24% 4.49%
Capitalization / Revenue 0.8 x 0.92 x 0.9 x 0.66 x 0.72 x 0.67 x 0.62 x 0.59 x
EV / Revenue 1.08 x 1.01 x 0.96 x 0.79 x 0.9 x 0.88 x 0.82 x 0.78 x
EV / EBITDA 8.64 x 9.4 x 6.04 x 5.51 x 11.7 x 11 x 7.65 x 6.51 x
EV / FCF 11.7 x 1,520 x 13.3 x 10.3 x 263 x 42.1 x 21.6 x 19 x
FCF Yield 8.52% 0.07% 7.53% 9.75% 0.38% 2.38% 4.64% 5.27%
Price to Book 2.02 x 1.57 x 1.71 x 1.39 x 1.33 x 1.28 x 1.25 x 1.19 x
Nbr of stocks (in thousands) 225,463 220,791 218,031 192,099 174,287 172,995 - -
Reference price 2 24.16 25.14 34.88 27.48 25.13 23.99 23.99 23.99
Announcement Date 2/13/20 2/12/21 2/15/22 2/21/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,797 6,018 8,453 8,023 6,111 6,231 6,740 7,071
EBITDA 1 846 647 1,343 1,155 472 496 719.1 845.5
EBIT 1 576 364 1,047 874 194 205.9 422.2 565.8
Operating Margin 8.47% 6.05% 12.39% 10.89% 3.17% 3.3% 6.26% 8%
Earnings before Tax (EBT) 1 391 337 1,313 697 99 206.3 429.6 -236.7
Net income 1 562 1,034 1,045 460 101 74.8 250.4 -99.87
Net margin 8.27% 17.18% 12.36% 5.73% 1.65% 1.2% 3.72% -1.41%
EPS 2 2.440 4.660 4.720 2.270 0.5700 0.5590 1.729 -2.680
Free Cash Flow 1 623 4 611 620 21 129.7 255.2 290
FCF margin 9.17% 0.07% 7.23% 7.73% 0.34% 2.08% 3.79% 4.1%
FCF Conversion (EBITDA) 73.64% 0.62% 45.5% 53.68% 4.45% 26.14% 35.49% 34.3%
FCF Conversion (Net income) 110.85% 0.39% 58.47% 134.78% 20.79% 173.36% 101.92% -
Dividend per Share 2 0.6500 0.6500 0.7500 0.8500 0.9500 0.9857 1.016 1.076
Announcement Date 2/13/20 2/12/21 2/15/22 2/21/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,285 2,307 2,389 2,362 2,011 1,650 1,606 1,596 1,506 1,403 1,471 1,611 1,607 1,536 1,698
EBITDA 1 371 349 415 432 271 87 136 156 136 44 76.4 128.2 155.5 131.4 162.7
EBIT 1 299 272 344 360 199 13 67 86 67 -26 4.121 55.56 83.16 56.7 92.59
Operating Margin 13.09% 11.79% 14.4% 15.24% 9.9% 0.79% 4.17% 5.39% 4.45% -1.85% 0.28% 3.45% 5.18% 3.69% 5.45%
Earnings before Tax (EBT) 1 268 699 304 309 146 -25 44 61 42 -59 2.788 54.16 80.21 55.2 107
Net income 1 209 597 223 228 100 -91 153 19 - -71 -11.88 21.47 38.14 19.54 66.7
Net margin 9.15% 25.88% 9.33% 9.65% 4.97% -5.52% 9.53% 1.19% - -5.06% -0.81% 1.33% 2.37% 1.27% 3.93%
EPS 2 0.9400 2.730 1.040 1.100 0.5000 -0.4800 0.8300 0.1100 - -0.4100 -0.0541 0.1634 0.2739 0.1777 0.4000
Dividend per Share 2 0.1875 0.2125 0.2125 0.2125 0.2125 0.2125 0.2375 0.2375 - 0.2375 0.2457 0.2457 0.2457 0.2457 0.2575
Announcement Date 10/29/21 2/15/22 4/28/22 8/2/22 11/4/22 2/21/23 5/5/23 7/31/23 10/31/23 2/21/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,864 528 509 1,083 1,148 1,306 1,353 1,352
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.203 x 0.8161 x 0.379 x 0.9377 x 2.432 x 2.633 x 1.881 x 1.599 x
Free Cash Flow 1 623 4 611 620 21 130 255 290
ROE (net income / shareholders' equity) 13.6% 7.03% 19.9% 15.9% 1.95% 3.11% 8.98% 11.8%
ROA (Net income/ Total Assets) 4.34% 2.56% 8.66% 7.22% 0.87% 0.48% 2.74% 3.93%
Assets 1 12,954 40,395 12,067 6,369 11,659 15,680 9,146 -2,543
Book Value Per Share 2 12.00 16.00 20.40 19.70 18.90 18.80 19.20 20.10
Cash Flow per Share 2 - 1.140 4.310 4.390 1.420 2.190 2.410 1.670
Capex 1 274 249 342 272 230 198 252 264
Capex / Sales 4.03% 4.14% 4.05% 3.39% 3.76% 3.18% 3.74% 3.73%
Announcement Date 2/13/20 2/12/21 2/15/22 2/21/23 2/21/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Huntsman Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
23.99 USD
Average target price
27.47 USD
Spread / Average Target
+14.49%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

1st Jan change Capi.
HUNTSMAN CORPORATION Stock Huntsman Corporation
-4.54% 4.15B
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
-0.19% 74.89B
BASF SE Stock BASF SE
+0.09% 46.52B
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
-4.19% 30.82B
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+9.85% 18.19B
BRENNTAG SE Stock Brenntag SE
-10.05% 11.54B
SYENSQO SA/NV Stock Syensqo SA/NV
-8.09% 9.73B
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
+2.79% 9.4B
SRF LIMITED Stock SRF Limited
+6.35% 9.37B
MITSUBISHI CHEMICAL GROUP CORPORATION Stock Mitsubishi Chemical Group Corporation
+3.85% 8.11B
Diversified Chemicals
  1. Stock Market
  2. Equities
  3. HUN Stock
  4. Financials Huntsman Corporation